Metastasis-directed Therapy of Regional and Distant Recurrences After Curative Treatment of Prostate Cancer: A Systematic Review of the Literature

Han, 2001, Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience, Urol Clin North Am, 28, 555, 10.1016/S0094-0143(05)70163-4

Joniau, 2015, Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study, Eur Urol, 67, 157, 10.1016/j.eururo.2014.01.020

Bolla, 2012, Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911), Lancet, 380, 2018, 10.1016/S0140-6736(12)61253-7

Palmbos, 2013, Non-castrate metastatic prostate cancer: have the treatment options changed?, Semin Oncol, 40, 337, 10.1053/j.seminoncol.2013.04.007

Heidenreich, 2014, EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer, Eur Urol, 65, 467, 10.1016/j.eururo.2013.11.002

Abrahamsson, 2010, Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature, Eur Urol, 57, 49, 10.1016/j.eururo.2009.07.049

Taylor, 2009, Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer, Cancer, 115, 2388, 10.1002/cncr.24283

Garcia-Yuste, 2010, The number of pulmonary metastases: influence on practice and outcome, J Thorac Oncol, 5, S161, 10.1097/JTO.0b013e3181dcf787

Spelt, 2012, Prognostic models for outcome following liver resection for colorectal cancer metastases: a systematic review, Eur J Surg Oncol, 38, 16, 10.1016/j.ejso.2011.10.013

Salah, 2012, Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model, Ann Oncol, 23, 2649, 10.1093/annonc/mds100

Ashworth, 2013, Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature, Lung Cancer, 82, 197, 10.1016/j.lungcan.2013.07.026

Tree, 2013, Stereotactic body radiotherapy for oligometastases, Lancet Oncol, 14, e28, 10.1016/S1470-2045(12)70510-7

Schweizer, 2013, Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy, Ann Oncol, 24, 2881, 10.1093/annonc/mdt335

Ost, 2014, Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer, Prostate, 74, 297, 10.1002/pros.22750

Weichselbaum, 2011, Oligometastases revisited, Nat Rev Clin Oncol, 8, 378, 10.1038/nrclinonc.2011.44

Treasure, 2014, Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness?, Thorax, 69, 946, 10.1136/thoraxjnl-2013-204528

Garden, 2006, Guidelines for resection of colorectal cancer liver metastases, Gut, 55, iii1

Kim, 2014, Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy, World J Urol, 32, 631, 10.1007/s00345-014-1293-6

Jadvar, 2011, Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline, J Nucl Med, 52, 81, 10.2967/jnumed.110.077941

Pasoglou, 2013, One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified “all-in-one” imaging approach?, Prostate, 74, 469, 10.1002/pros.22764

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097

Moga C, Guo B, Schopflocher D, Harstall C. Development of a quality appraisal tool for case series studies using a modified Delphi technique. Institute of Health Economics Web site. http://www.ihe.ca/documents/Case%20series%20studies%20using%20a%20modified%20Delphi%20technique.pdf.

Casamassima, 2011, Efficacy of eradicative radiotherapy for limited nodal metastases detected with choline PET scan in prostate cancer patients, Tumori, 97, 49, 10.1177/030089161109700110

Muacevic, 2011, Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer, Urol Oncol, 31, 455, 10.1016/j.urolonc.2011.02.023

Würschmidt, 2011, [18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes, Radiat Oncol, 6, 44, 10.1186/1748-717X-6-44

Ahmed, 2012, Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer, Front Oncol, 2, 215

Jereczek-Fossa, 2012, Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer, Int J Radiat Oncol Biol Phys, 82, 889, 10.1016/j.ijrobp.2010.11.031

Schick, 2013, Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases, Acta Oncol, 52, 1622, 10.3109/0284186X.2013.764010

Decaestecker, 2014, Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence, Radiat Oncol, 9, 135, 10.1186/1748-717X-9-135

Picchio, 2014, (11)C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients, Eur J Nucl Med Mol Imaging, 41, 1270

Rinnab, 2008, [11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study, Urol Int, 81, 191, 10.1159/000144059

Schilling, 2008, Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer, BJU Int, 102, 446, 10.1111/j.1464-410X.2008.07592.x

Winter, 2010, First results of [11C]choline PET/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy, Urol Int, 84, 418, 10.1159/000296298

Jilg, 2012, Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer, J Urol, 188, 2190, 10.1016/j.juro.2012.08.041

Martini, 2012, The role of C-choline-PET/CT-guided secondary lymphadenectomy in patients with PSA failure after radical prostatectomy: lessons learned from eight cases, Adv Urol, 2012, 601572, 10.1155/2012/601572

Suardi, 2015, Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years, Eur Urol, 67, 299, 10.1016/j.eururo.2014.02.011

Busch, 2012, Selective lymph node dissection for castration-resistant prostate cancer, Urol Int, 88, 441, 10.1159/000335206

Trotti, 2003, CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment, Semin Radiat Oncol, 13, 176, 10.1016/S1053-4296(03)00031-6

Cox, 1995, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC), Int J Radiat Oncol Biol Phys, 31, 1341, 10.1016/0360-3016(95)00060-C

Dindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, 240, 205, 10.1097/01.sla.0000133083.54934.ae

Durante, 2013, Immunologically augmented cancer treatment using modern radiotherapy, Trends Mol Med, 19, 565, 10.1016/j.molmed.2013.05.007

Umbehr, 2013, The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis, Eur Urol, 64, 106, 10.1016/j.eururo.2013.04.019

Wondergem, 2013, A literature review of 18F-fluoride PET/CT and 18F-choline or 11C-choline PET/CT for detection of bone metastases in patients with prostate cancer, Nucl Med Commun, 34, 935, 10.1097/MNM.0b013e328364918a

Tilki, 2013, 18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent, Eur Urol, 63, 792, 10.1016/j.eururo.2012.08.003

Passoni, 2014, Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series, Urol Oncol, 32, 10.1016/j.urolonc.2013.03.006

Jilg, 2014, Detection of lymph node metastasis in patients with nodal prostate cancer relapse using 18F/11C-choline positron emission tomography/computerized tomography, J Urol, 192, 103, 10.1016/j.juro.2013.12.054

Abdollah, 2015, Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy, Eur Urol, 67, 839, 10.1016/j.eururo.2014.03.019

Lecouvet, 2012, Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?, Eur Urol, 62, 68, 10.1016/j.eururo.2012.02.020

Corbin, 2013, Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy, J Clin Oncol, 31, 1384, 10.1200/JCO.2012.45.9651